TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding October 9, 1987